See also this year's filing and all EDGAR filings for this company.
PDF Report 0001472012_2022_Immunome_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001472012, Immunome Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 56,638,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 855,000 |
| 3 | remainder_Assets | 432,000 |
| 4 | LiabilitiesCurrent | 9,728,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 12,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,094,000 |
| 9 | ResearchAndDevelopmentExpense | 14,110,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 493,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 57,925,000 |
| 1 | Liabilities | 9,740,000 |
| 2 | Expenses | 25,204,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 48,185,000 |
| 5 | NetIncome | -24,711,000 |
| 6 | ComprehensiveNetIncome | -24,711,000 |
| 7 | BaseVar | 46,681,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.37 |
| 9 | EconomicCapitalRatio | 3.27 |